Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia 33Breast Neoplasms 20Leukemia, Myeloid, Acute 15Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 13Head and Neck Neoplasms 13Congenital Abnormalities 12Squamous Cell Carcinoma of Head and Neck 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma 9Kidney Neoplasms 9Central Nervous System Neoplasms 9Sarcoma 8Rectal Neoplasms 8Leukemia, Megakaryoblastic, Acute 8Colorectal Neoplasms 8Colonic Neoplasms 8Lymphoma, Follicular 7Leukemia, Myelomonocytic, Acute 7Leukemia, Monocytic, Acute 7Leukemia, Erythroblastic, Acute 7Gliosarcoma 7Glioblastoma 7Multiple Myeloma 6Melanoma 6Neuroblastoma 5Lymphoma, Large B-Cell, Diffuse 5Esophageal Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Wilms Tumor 4

Interventions

eltrombopag 8romiplostim 5Cytarabine 4Filgrastim 3Etoposide 3Daunorubicin 3Carboplatin 3oprelvekin 2fludarabine phosphate 2avatrombopag 2Thrombopoietin 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Lenalidomide 2Interleukin-11 2Ifosfamide 2Doxorubicin 2Cyclosporine 2Busulfan 2sargramostim 1ofatumumab 1lusutrombopag 1leridistim 1bryostatin 1 1angiotensin I (1-7) 1alvocidib 1Vitamin E 1Vitamin B 12 1Vincristine 1Tranexamic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Thrombocytopenia × Gene Expression Profiling × Clear all
NCT01165996 2019-03-04

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome

Case Comprehensive Cancer Center

Phase 1/2 Completed
25 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡